Sagimet Biosciences reported net income of -$14.04M for the quarter ended Jun 2026. This income statement covers 17 quarters of results from Jun 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.19M | 0.19M | 0.19M | 0.19M | 0.21M | 22.90M | 22.90M | 29.04M | 31.91M | 32.14M | 31.35M | 32.20M | 32.20M | 32.46M | 32.35M | 32.56M | 53.11M |
| Revenue & cost | |||||||||||||||||
| Revenue | 2.00M | ||||||||||||||||
| Operating items | |||||||||||||||||
| Research & DevelopmentR&D | 6.37M | 6.84M | 5.85M | 4.49M | 4.68M | 4.96M | 5.66M | 5.26M | 6.31M | 12.65M | 14.22M | 15.34M | 7.25M | 9.73M | 6.73M | 7.00M | 11.54M |
| Wages, Salaries and OtherWages | 1.48M | 1.52M | 1.71M | 1.82M | 1.95M | 1.77M | 1.73M | 1.69M | 2.17M | 2.09M | |||||||
| Selling, General & AdministrativeSG&A | 0.87M | 0.85M | 1.54M | 2.28M | 2.38M | 4.49M | 3.81M | 3.51M | 4.28M | 4.25M | 3.98M | 4.52M | 4.68M | 4.60M | 4.03M | 4.72M | 4.28M |
| Operating ExpensesOpex | 7.24M | 7.69M | 7.39M | 6.76M | 7.06M | 9.45M | 9.47M | 8.77M | 10.59M | 16.90M | 18.20M | 19.86M | 11.93M | 14.33M | 10.77M | 11.71M | 15.82M |
| Operating IncomeOp. Inc | -7.24M | -7.69M | -7.39M | -6.76M | -7.06M | -7.45M | -9.47M | -8.77M | -10.59M | -16.90M | -18.20M | -19.86M | -11.93M | -14.33M | -10.77M | -11.71M | -15.82M |
| EBIT | -7.24M | -7.69M | -7.39M | -6.76M | -7.06M | -7.45M | -9.47M | -8.77M | -10.59M | -16.90M | -18.20M | -19.86M | -11.93M | -14.33M | -10.77M | -11.71M | -15.82M |
| Non-operating items | |||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | -0.11M | 0.22M | 0.19M | 0.07M | 0.01M | 1.09M | 1.31M | -0.02M | -0.03M | 2.28M | 1.99M | -0.11M | 1.54M | 1.43M | 1.20M | -0.11M | 1.86M |
| Other Non Operating IncomeOther Non Op Inc. | 0.14M | 0.22M | 0.19M | 0.18M | 0.27M | 1.10M | 1.31M | 2.14M | 2.47M | 2.28M | 1.99M | 1.69M | 1.54M | 1.43M | 1.20M | 1.06M | 1.86M |
| Net income details | |||||||||||||||||
| EBT | -7.34M | -7.47M | -7.20M | -6.69M | -7.04M | -6.36M | -8.15M | -8.79M | -10.62M | -14.62M | -16.20M | -19.97M | -10.39M | -12.91M | -9.57M | -11.82M | -13.95M |
| Profit After TaxPAT | -7.10M | -7.52M | -7.12M | -6.59M | -6.79M | -6.35M | -8.15M | -6.63M | -8.12M | -14.62M | -16.20M | -18.18M | -10.43M | -12.91M | -9.56M | -10.65M | -14.04M |
| Income from Continuing OperationsIncome (Continuing) | -7.34M | -7.47M | -7.20M | -6.69M | -7.04M | -6.36M | -8.15M | -8.79M | -10.62M | -14.62M | -16.20M | -19.97M | -10.39M | -12.91M | -9.57M | -11.82M | -13.95M |
| Consolidated Net IncomeConsol Net Inc. | -7.34M | -7.47M | -7.20M | -6.69M | -7.04M | -6.36M | -8.15M | -8.79M | -10.62M | -14.62M | -16.20M | -19.97M | -10.39M | -12.91M | -9.57M | -11.82M | -13.95M |
| Income towards Parent CompanyParent Net Inc | -7.34M | -7.47M | -7.20M | -6.69M | -7.04M | -6.36M | -8.15M | -8.79M | -10.62M | -14.62M | -16.20M | -19.97M | -10.39M | -12.91M | -9.57M | -11.82M | -13.95M |
| Net Income towards Common StockholdersNet Income | -7.34M | -7.47M | -7.20M | -6.69M | -7.04M | -6.36M | -8.15M | -8.79M | -10.62M | -14.62M | -16.20M | -19.97M | -10.39M | -12.91M | -9.57M | -11.82M | -13.95M |
| Additional items | |||||||||||||||||
| EPS (Basic) | -39.68 | -40.35 | -38.97 | -36.16 | -37.17 | -0.35 | -0.78 | -0.30 | -0.33 | -0.45 | -0.52 | -0.62 | -0.32 | -0.40 | -0.30 | -0.36 | -0.26 |
| EPS (Diluted) | -39.68 | -40.35 | -38.97 | -36.16 | -37.17 | -0.35 | -0.78 | -0.30 | -0.33 | -0.45 | -0.52 | -0.62 | -0.32 | -0.40 | -0.30 | -0.36 | -0.26 |
| Shares Outstanding | 0.19M | 0.19M | 0.18M | 0.19M | 0.19M | 18.19M | 10.46M | 29.04M | 31.91M | 32.14M | 31.35M | 32.20M | 32.20M | 32.46M | 32.35M | 32.56M | 53.11M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.19M | 0.19M | 0.18M | 0.19M | 0.19M | 18.19M | 10.46M | 29.04M | 31.91M | 32.14M | 31.35M | 32.20M | 32.20M | 32.46M | 32.35M | 32.56M | 53.11M |
| EBITDA | -7.24M | -7.69M | -7.39M | -6.76M | -7.06M | -7.45M | -9.47M | -8.77M | -10.59M | -16.90M | -18.20M | -19.86M | -11.93M | -14.33M | -10.77M | -11.71M | -15.82M |